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Rickettsia mongolotimonae (1) was first
obtained as isolate HA-91 from Hyalomma
asiaticum, a tick collected in Inner Mongolia in
1991 (2). The first evidence of R. mongolotimonae
pathogenicity in humans was obtained in our
laboratory in 1996 in a woman who had an
atypical tick-transmitted disease. This second
case of R. mongolotimonae infection was
unexpected, especially because the symptoms in
the second case differed from those of the first
case and of other rickettsioses cases.
On May 19, 1998, a 49-year-old HIV-positive
man was admitted to a hospital in Marseille,
France, with fever and myalgias for 5 days. The
patient, who had been HIV positive since 1988,
was being treated with a combination of
zidovudine, lamivudine, and nevirapine. With
this therapy, he had been asymptomatic for 5
years. His CD4+ lymphocyte count was 503/µL,
and his plasma viral level was 5,916 copies per ml
(3.77 log). He was a gardener who lived in a rural
area 40 km from Marseille and had contact with
animals, including cats, rabbits, squirrels, and
birds. On May 8, 1998, he worked in his garden
but did not notice any tick bites. On examination
the day of admission, he had an eschar (tache
noire) surrounded by an inflammatory halo on his
left leg. He had a fever of 39°C, chills, headache,
and myalgias. A lymphangitis expanded from the
inoculation eschar to the left groin, where a
painful satellite lymphadenopathy was observed
(Figure). Clinical examination was otherwise
normal. Laboratory results were unremarkable.
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We report a second case of laboratory-confirmed infection caused by Rickettsia
mongolotimonae in Marseille, France. This rickettsiosis may represent a new clinical
entity; moreover, its geographic distribution may be broader than previously
documented. This pathogen should be systematically considered in the differential
diagnosis of atypical rickettsioses, especially rashless fevers with lymphangitis and
lymphadenopathy, in southern France and perhaps elsewhere.
Figure. Lymphangitis expanding from the inocula-
tion eschar on the left leg to an enlarged, painful
lymph node on the left groin of a patient with
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An acute-phase serum sample drawn that day
was sent to our laboratory, along with a biopsy of
the eschar. Although the patient had no rash,
Mediterranean spotted fever was suspected.
After 15 days of treatment with 200 mg per day of
doxycycline, the symptoms resolved. A second
serum sample was collected on May 26.
Microimmunofluorescence testing was per-
formed (3). Although the first serologic test was
negative, the second serum sample had low titers
to R. mongolotimonae and R. conorii (1:16 for
immunoglobulin [Ig] G and 1:16 for IgM). The
eschar sample was spread onto human embryon-
ic lung fibroblasts by the centrifugation shell-vial
technique (4). After 7 days incubation at 32°C, a
Gimenez staining of methanol-fixed human
embryonic lung fibroblasts cells showed Rickett-
sia-like bacilli. DNA was extracted from the
ground eschar biopsy and from 200 µL of shell-
vial supernatant, by using a QIAmp Tissue kit
(QIAGEN GmbH, Hilden, Germany) according to
the manufacturer’s instructions. These extracts
were used as templates with primers complemen-
tary to portions of the coding sequences of the
rOmpA, citrate synthase, and 16S rRNA encoding
genes in three polymerase chain reaction (PCR)
assays (5). The base sequences of the obtained PCR
products were determined (5). All sequences
shared 100% similarity with R. mongolotimonae
when compared with GenBank data.
Eight new rickettsioses, three of which were
described in Europe, have been identified in the
past 13 years, including Japanese spotted fever due
to R. japonica; Astrakhan fever due to Astrakhan
fever rickettsia; Flinder’s Island spotted fever
due to R. honei; cat flea typhus due to R. felis;
African tick-bite fever due to R. africae; and the
proposed rickettsioses due to R. mongolotimonae
(1), R. slovaca (6), and R. helvetica (7). R. conorii,
responsible for Mediterranean spotted fever, has
long been considered the only tick-transmitted
European rickettsia in the Mediterranean Sea
area. However, the results of this and previous
studies (1,6) indicate that both R. mongolotimonae
and R. slovaca are agents of human rickettsioses
in France.
In the only reported case of R. mongolotimonae
infection in France, migratory birds carrying
ticks were hypothesized to be responsible for
transmitting the infection, as R. mongolotimonae
had been isolated only from ticks from China (1).
On the basis of this hypothesis, the initial case
was thought to be a unique imported infection.
However, the occurrence of a second case in the
same area suggests that the disease may be more
common than expected around Marseille. R.
mongolotimonae was initially isolated from
Hyalomma asiaticum ticks in China, but its
reservoir in our area is unknown. However, the
fact that the patient worked in a garden near
cypress trees where numerous birds nested
suggests that migratory birds should be
considered a possible source. We were unable to
detect this bacterium by using ompA PCR-
amplification and culture in 540 Rhipicephalus
ticks from the Marseille area; these ticks are
prevalent in southern France (8,9). An active
search for the vector of R. mongolotimonae,
which may be a rare tick species in Southern
France, should be conducted.
The symptoms of both patients occurred in
spring, which is unusual for Mediterranean
spotted fever (1). The symptoms of the first
patient were like those of Mediterranean spotted
fever, except that the rash was discrete. The
second patient had no rash but had lymphangitis,
expanding from the inoculation eschar to the
groin, and a painful lymphadenopathy. These
differences in clinical symptoms may be
explained by the HIV-positive status of this
patient. Two cases are inadequate to describe a
disease; however, our preliminary data suggest
that R. mongolotimonae infections may have a
discrete rash or no rash, along with lymphangitis
and satellite lymphadenopathy.
This second case of R. mongolotimonae
infection is important for several reasons. First,
this rickettsiosis may represent a new clinical
entity. Second, the geographic distribution of the
illness may be broader than previously docu-
mented. R. mongolotimonae should be systemati-
cally considered in the differential diagnosis of
atypical rickettsioses in southern France,
especially fevers without rash but with lymphan-
gitis and lymphadenopathy, in southern France
and perhaps elsewhere.
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